Oxford BioMedica PLC (OXB:LSE) Annual Income Statement ()
OXB:LSE Quarterly Financials ()
Frequently Asked Questions About Oxford BioMedica PLC (OXB:LSE) Stock
Oxford BioMedica PLC's (OXB:LSE) last reported annual revenue was GBX 139.99 Million.
Oxford BioMedica PLC's (OXB:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 30.08%
Oxford BioMedica PLC's(OXB:LSE) is not profitable as of its last reported annual financials.
The net profit margin for Oxford BioMedica PLC's(OXB:LSE) from its laster reported year is -32.26%
The return on equity (ROE) for Oxford BioMedica PLC's(OXB:LSE) from its last reported annual financials is : -30.64%
The return on assets (ROA) for Oxford BioMedica PLC's(OXB:LSE) from its last reported annual financials is : -12.05%
The return on invested capital (ROIC) for Oxford BioMedica PLC's(OXB:LSE) from its last reported annual financials is : -23.50%
The Debt to Equity ratio for Oxford BioMedica PLC's(OXB:LSE) from its last reported annual financials is : 19.44%
The dividend yield for Oxford BioMedica PLC's(OXB:LSE) from its laster reported year is 0.00%
Oxford BioMedica PLC's(OXB:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OXB:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
